DV
Dividend Vision

MGNX — MacroGenics Inc

MacroGenics Inc (MGNX)

Total return is -83.1% over the past 12.8 years, 552.6 points behind SPY at 469.5%. Its deepest 1-year drawdown was 34.2%.

MGNX is an equity stock focused on MacroGenics Inc, a biotechnology company. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular yield. This holding appeals primarily to growth-oriented investors interested in exposure to the biotechnology sector rather than dividend income strategies.

MGNX key facts

Asset type
Stock
Asset class
Equity
Inception date
10/10/2013
Last close
$4.22
Market cap
$274,592,704
Average volume
851459.0
Beta
1.179
Payout ratio
0.0
Forward P/E
60.9756
EPS
$-1.07